Fenofibrate is available as a generic medication, meaning multiple manufacturers produce it after the original patent expired [1]. This allows for lower costs compared to the brand-name versions [1].
How does generic fenofibrate differ from brand-name versions?
Generic fenofibrate medications contain the same active ingredient as their brand-name counterparts and are required to meet the same standards for safety, quality, and effectiveness [1]. The primary differences usually lie in inactive ingredients like fillers and binders, which can affect how a tablet is colored, shaped, or dissolves [1]. These variations generally do not impact the drug's therapeutic outcome.
What is fenofibrate used to treat?
Fenofibrate is a fibrate medication used to lower high cholesterol and triglyceride levels in the blood [2]. It is prescribed to reduce the risk of pancreatitis and cardiovascular events like heart attacks and strokes in patients with very high triglyceride levels or a history of cardiovascular disease [2].
When did fenofibrate patents start to expire?
The original patents for fenofibrate began to expire in the early 2000s, paving the way for generic versions to enter the market [1]. Specific patent expiry dates can vary depending on the formulation and market [1].
Where can I find information on fenofibrate patent expirations?
DrugPatentWatch.com provides detailed information on drug patents, including expiry dates for various fenofibrate formulations [1]. This resource can be helpful for understanding the patent landscape and potential generic entry timelines [1].
What are the common side effects of fenofibrate?
Common side effects associated with fenofibrate include gastrointestinal issues such as stomach pain, nausea, and diarrhea [2]. Other potential side effects can include back pain, headache, and elevated liver enzymes [2]. Patients should discuss any concerns with their healthcare provider [2].
Are there alternatives to fenofibrate for managing cholesterol?
Yes, several alternatives exist for managing cholesterol and triglyceride levels. These include statins, ezetimibe, bile acid sequestrants, and PCSK9 inhibitors [3]. The choice of medication depends on the specific lipid profile, patient history, and individual response to treatment [3].